GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:22731401

From GONUTS
Jump to: navigation, search
Citation

Ngamskulrungroj, P, Chang, Y, Hansen, B, Bugge, C, Fischer, E and Kwon-Chung, KJ (2012) Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation. FEMS Yeast Res. 12:748-54

Abstract

Cryptococcus neoformans, an opportunistic fungal pathogen, manifests an intrinsic adaptive mechanism of resistance toward fluconazole (FLC) termed heteroresistance. Heteroresistance is characterized by the emergence of minor resistant subpopulations at levels of FLC that are higher than the strain's minimum inhibitory concentration. The heteroresistant clones that tolerate high concentrations of FLC often contain disomic chromosome 4 (Chr4). SEY1 , GLO3 , and GCS2 on Chr4 are responsible for endoplasmic reticulum (ER) integrity and important for Chr4 disomy formation under FLC stress. We sought an evidence of a direct relationship between ER morphology and Chr4 disomy formation. Deletion of the YOP1 gene on Chr7, which encodes an ER curvature-stabilizing protein that interacts with Sey1 , perturbed ER morphology without affecting FLC susceptibility or the frequency of FLC-induced disomies. However, deletion of both YOP1 and SEY1 , not only perturbed ER morphology more severely than in sey1∆ or yop1∆ strains, but also abrogated the FLC-induced disomy. Although the heteroresistance phenotype was retained in the sey1∆yop1∆ strains, tolerance to FLC appeared to have resulted not from chromosome duplication but from gene amplification restricted to the region surrounding ERG11 on Chr1. These data support the importance of ER integrity in C. neoformans for the formation of disomy under FLC stress.

Links

PubMed PMC3472080 Online version:10.1111/j.1567-1364.2012.00824.x

Keywords

Aneuploidy; Antifungal Agents/pharmacology; Cryptococcus neoformans/drug effects; Cryptococcus neoformans/genetics; Cryptococcus neoformans/metabolism; Cryptococcus neoformans/ultrastructure; Drug Resistance, Fungal; Endoplasmic Reticulum/metabolism; Endoplasmic Reticulum/ultrastructure; Fluconazole/pharmacology; Fungal Proteins/genetics; Fungal Proteins/metabolism; Gene Amplification; Gene Deletion

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

CRYNH:J9VRC5

GO:0071786: endoplasmic reticulum tubular network organization

ECO:0000315:

P

Figure 2 shows the ER (artificially labeled in green color) morphology in yop1Δ was aberrant and was observed mostly as an expanded sheet in contrast to the reticulate ER of the wild-type cell.

complete
CACAO 11263

CRYNH:J9VP90

GO:0071786: endoplasmic reticulum tubular network organization

ECO:0000315:

P

Figure 2 shows the ER (artificially labeled in green color) morphology in sey1Δ was aberrant and was observed mostly as an expanded sheet in contrast to the reticulate ER of the wild-type cell.

complete
CACAO 11262

Notes

See also

References

See Help:References for how to manage references in GONUTS.